strategy
Reforming pharmaceutical usage in public health
Context:
Pharmaceuticals account for 10 to 30% of public spending for health in most countries. Very large savings can be achieved by improving the selection and quantification of drug requirements. Implementation:
Governments that have introduced competition in the procurement of drugs have typically achieved savings of 40 to 60%. This is aided by developing using national essential drug lists, consisting of a limited number of inexpensive drugs that address the important health problems of the population, and developing country-specific treatment protocols. An essential-drugs revolving fund for several Central American nations yielded savings of 65% of the costs of the pharmaceuticals. Narrower:
Limiting medical drugsUsing generic pharmaceuticalsReducing number of medical drugsPurchasing basic medical drugs in bulkQuestioning superiority of expensive drugs Problems:
Corporate crime in the pharmaceutical industryIllicit trade in prescribed drugs
Ineffective self-regulation in the pharmaceutical and medical devices industries
Underdevelopment of the pharmaceutical industry
Unethical pharmaceutical practices
Values:
Health Subjects:
Health Care → HealthHealth Care → Pharmacy
Government → Public
Development → Reform
Type Classification:
D: Detailed strategies Related UN Sustainable Development Goals:
